These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10764951)
21. Potent and selective peptide agonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro. Bednarek MA; MacNeil T; Tang R; Kalyani RN; Van der Ploeg LH; Weinberg DH Biochem Biophys Res Commun; 2001 Aug; 286(3):641-5. PubMed ID: 11511108 [TBL] [Abstract][Full Text] [Related]
22. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432 [TBL] [Abstract][Full Text] [Related]
29. Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors. Grieco P; Lavecchia A; Cai M; Trivedi D; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ J Med Chem; 2002 Nov; 45(24):5287-94. PubMed ID: 12431055 [TBL] [Abstract][Full Text] [Related]
30. Activation of melanocortin MC(4) receptors increases erectile activity in rats ex copula. Martin WJ; McGowan E; Cashen DE; Gantert LT; Drisko JE; Hom GJ; Nargund R; Sebhat I; Howard AD; Van der Ploeg LH; MacIntyre DE Eur J Pharmacol; 2002 Nov; 454(1):71-9. PubMed ID: 12409007 [TBL] [Abstract][Full Text] [Related]
31. Major pharmacological distinction of the ACTH receptor from other melanocortin receptors. Schiöth HB; Chhajlani V; Muceniece R; Klusa V; Wikberg JE Life Sci; 1996; 59(10):797-801. PubMed ID: 8761313 [TBL] [Abstract][Full Text] [Related]
32. Selectivity of [Phe-I7], [Ala6], and [D-Ala4,Gln5,Tyr6] substituted ACTH(4-10) analogues for the melanocortin receptors. Schiöth HB; Muceniece R; Wikberg JE Peptides; 1997; 18(5):761-3. PubMed ID: 9213373 [TBL] [Abstract][Full Text] [Related]
33. Body weight regulation by selective MC4 receptor agonists and antagonists. Foster AC; Joppa M; Markison S; Gogas KR; Fleck BA; Murphy BJ; Wolff M; Cismowski MJ; Ling N; Goodfellow VS; Chen C; Saunders J; Conlon PJ Ann N Y Acad Sci; 2003 Jun; 994():103-10. PubMed ID: 12851304 [TBL] [Abstract][Full Text] [Related]
35. Chimeric melanocortin MC1 and MC3 receptors: identification of domains participating in binding of melanocyte-stimulating hormone peptides. Schiöth HB; Yook P; Muceniece R; Wikberg JE; Szardenings M Mol Pharmacol; 1998 Jul; 54(1):154-61. PubMed ID: 9658201 [TBL] [Abstract][Full Text] [Related]
36. Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs. Mayorov AV; Han SY; Cai M; Hammer MR; Trivedi D; Hruby VJ Chem Biol Drug Des; 2006 May; 67(5):329-35. PubMed ID: 16784457 [TBL] [Abstract][Full Text] [Related]
37. Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors. Kavarana MJ; Trivedi D; Cai M; Ying J; Hammer M; Cabello C; Grieco P; Han G; Hruby VJ J Med Chem; 2002 Jun; 45(12):2644-50. PubMed ID: 12036373 [TBL] [Abstract][Full Text] [Related]
38. The MC3 receptor binding affinity of melanocortins correlates with the nitric oxide production inhibition in mice brain inflammation model. Muceniece R; Zvejniece L; Liepinsh E; Kirjanova O; Baumane L; Petrovska R; Mutulis F; Mutule I; Kalvinsh I; Wikberg JE; Dambrova M Peptides; 2006 Jun; 27(6):1443-50. PubMed ID: 16414147 [TBL] [Abstract][Full Text] [Related]
39. Synthetic melanocortin receptor agonists and antagonists. Lerner MR Ann N Y Acad Sci; 1999 Oct; 885():153-60. PubMed ID: 10816648 [TBL] [Abstract][Full Text] [Related]